10 months in and dose escalation is still the thing I get wrong
Check-in as promised in the title: 10 months in and dose escalation is still the thing I get wrong.
10 months. Those are measured, not estimated, and not rounded up in my favour.
Kept a log specifically because there is so little published. It is one person and it is not data.
The thing that surprised me was how much of the discussion here is inference rather than measurement.
That is everything I have. The rest is opinion and I have tried to keep it out.
best — the order this archive was captured in
Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.
Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.
This. The phase 2 result was genuinely large and it was also 48 weeks in a few hundred people.